Search

everythinglearnresearchcommunity

for

Search:↓

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Abnormal growth factor metabolism may link psoriasis and metabolic syndrome, and obesity can affect psoriasis treatment effectiveness.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Adalimumab can cause complete hair loss in rare cases.

Patients need better information about the risks of long-term steroid use.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

The ILDS Newsletter reported on efforts to support albinism patients in Tanzania and dermatological conferences.

Personalized care and evidence-based treatments are crucial for managing skin and hair conditions.

Certain factors like being female, having high cholesterol, using Medicaid, and previous non-biologic treatments increase the risk of multiple biologic failures in psoriasis patients.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Improving education, training, and access to affordable treatments is crucial for better managing inflammatory skin diseases in Latin America.

Blocking interferon-gamma might help treat various autoimmune diseases.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.